Guzman, A. 2018. Topical Cantharidin Revisited: A Phase 2 Study Investigating a Commercially-Viable Formulation of Cantharidin (VP-102) for the Treatment of Molluscum Contagiosum. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S103-S104. DOI:https://doi.org/10.25251/skin.2.supp.98.